Evidence map›Paper›PMID 42088862›Full record

ArticleCurrent research in food science2026

Liposomal and chitosan-coated liposomal nanocarriers for grape seed proanthocyanidins: Integrated physicochemical, cellular, and rheological characterization.

Johana López-Polo, Jaime Romero, Alejandro Villasante, Rafael Opazo, Ayleen Hormazábal-Daber, Gonzalo Jorquera, Pamela J Urrutia, Fernando A Osorio, Jocelyn Fuentes, Hernán Speisky and 4 more

Abstract read
In one paragraph

Article in Current research in food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Johana López-PoloLaboratorio de Biotecnología de los Alimentos, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago, 783090, Chile.
Jaime RomeroLaboratorio de Biotecnología de los Alimentos, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago, 783090, Chile.
Alejandro VillasanteLaboratorio de Biotecnología de los Alimentos, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago, 783090, Chile.
Rafael OpazoLaboratorio de Biotecnología de los Alimentos, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago, 783090, Chile.
Ayleen Hormazábal-DaberLaboratorio de Biotecnología de los Alimentos, Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago, 783090, Chile.
Gonzalo JorqueraResilient Aging Laboratory, Institute for Nutrition and Food Technology (INTA), Universidad de Chile, Santiago, 783090, Chile.
Pamela J UrrutiaResilient Aging Laboratory, Institute for Nutrition and Food Technology (INTA), Universidad de Chile, Santiago, 783090, Chile.
Fernando A OsorioDepartment of Food Science and Technology, Universidad de Santiago de Chile (USACH), Santiago, Chile.
Jocelyn FuentesLaboratory of Antioxidants, Nutrition and Food Technology Institute, University of Chile, Santiago, Chile.
Hernán SpeiskyLaboratory of Antioxidants, Nutrition and Food Technology Institute, University of Chile, Santiago, Chile.
Cristian Patiño VidalUniversidad Nacional de Chimborazo (UNACH), Faculty of Engineering, Safety and Resources Valorization Research Group (INVAGRO), Riobamba, Ecuador.
Jimena CorderoAdvance Center for Chronic Diseases (ACCDiS), Santiago, Chile.
Juan M RusoSoft Matter and Molecular Biophysics Group, Department of Applied Physics and Institute of Materials (iMATUS), University of Santiago de Compostela, Santiago de Compostela, 15782, Spain.
Felipe A Oyarzun-AmpueroAdvance Center for Chronic Diseases (ACCDiS), Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioactive compounds derived from grape by-products support a circular economy approach and offer valuable opportunities for the nutraceutical and food industries. Among these by-products, grape seeds are of particular interest due to their high content of antioxidant proanthocyanidins (PAs). However, the aqueous solubility and chemical instability of PAs during processing, storage and consumption, limit their commercial viability. We hypothesize that an optimization in the PAs encapsulation would improve their physicochemical and biological performance, and the potential to be included in food formulations. In this study, we developed liposomes (Lip) as delivery systems for grape seed PAs and evaluated the effect of a chitosan (Cs) coating on their physicochemical properties, cellular responses, and rheological behavior. Both Lip and Cs/Lip formulations displayed high encapsulation efficiency (>90%) and presented particle sizes of 120-150 nm with low polydispersity. Storage studies demonstrated excellent colloidal stability, PAs retention, and antioxidant activity. Viability assays in Caco-2 and SH-SY5Y (neuroblastoma) cell lines confirmed the safety of the formulations and revealed increased viability at the highest tested concentrations (50 μg/mL in Caco-2: PAs-Lip increase 32% and PAs-Cs/Lip increase 24%; 1 μg/mL in SH-SY5Y: PAs-Lip increase 27% and PAs-Cs/Lip increase 40%). Notably, PAs encapsulation reduced the cytotoxic effects induced by the oxidant agent tert-butyl hydroperoxide, with Cs/Lip exhibiting the strongest protective activity. In summary, the developed formulations, due to their safety, stability, potential to increase cell viability, and rheological compatibility with aqueous-based formulations, represent interesting ingredients to be included in food products and convert them into functional foods.

Indexed as

AntioxidantsChitosanEncapsulationLiposomesProanthocyanidins

Identifiers

PMID42088862
PMCPMC13136772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.